Use of Systemic Anticoagulation in COVID-19: Delving Beyond Theoretical Hypothesis

Background Studies suggest that COVID-19 infection may induce increased hypercoagulability, leading to thrombotic complications. The high rates of thrombotic complications among patients receiving standard-dose deep venous thrombosis (DVT) prophylaxis have prompted some clinicians to support the emp...

Descripción completa

Detalles Bibliográficos
Autores principales: Millet, Christopher, Narvaneni, Spandana, Shafeek, Fady, Roman, Sherif, Mechineni, Ashesha, Manickam, Rajapriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916688/
https://www.ncbi.nlm.nih.gov/pubmed/35340525
http://dx.doi.org/10.7759/cureus.22061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916688/
https://www.ncbi.nlm.nih.gov/pubmed/35340525
http://dx.doi.org/10.7759/cureus.22061

Ejemplares similares